In terms of the usage of the net proceeds from the offering, Akamai plans to use a portion to repay approximately $250.0 ...

In the Management’s Discussion and Analysis of Financial Condition and Results of Operations, KinderCare outlined several key ...

In the 10-Q report, ZEVRA THERAPEUTICS, INC. discussed its financial condition and results of operations. The company ...

The 2029 convertible notes will be senior, unsecured obligations of Bloom Energy and will accrue interest at a rate of 3.00% ...

The Electrical and Mechanical (E&M) segment witnessed significant growth, with revenues up by 47.0% to $648.2 million in the ...

The transaction is expected to be funded with a combination of equity issued to H&E shareholders, a $1 billion draw under an ...

Adaptimmune Therapeutics PLC has reported its financial results for the first quarter ended March 31, 2025, and provided a ...

Standing out among the Street's worst performers today is Simon Property, a specialty real estate investment trust company ...

Carlyle has a P/E ratio of 15.8 based on its 12 month trailing earnings per share of $2.94. Considering its future earnings ...

13 analysts are following Altria and have set target prices ranging from $47.0 to $73.0 per share. On average, they have ...

Value investors believe that owning a stock is owning a slice of the underlying business… but this isn’t always true. ...

T-Mobile US's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 2.8 ...